experts in cGMP gene and cell therapy manufacturing
Company Details
- Employees
- 13
- Founded
- -
- Address
- 1450 Biggy St,
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Keywords
- Show more similar pages.
- HQ
- Los Angeles, California
- Competitors
- Allogene Therapeutics, Northwestern Medicine Department of Ophthalmology, Keck Medicine of USC, AMERICAN CHINESE PHARMACEUTICAL ASSOCIATION, Cedars-Sinai Biomanufacturing Center, Innovative Strategies & Solutions Inc., Children's Hospital Los Angeles (CHLA), Cedars-Sinai Technology Ventures, Women's Community Center @ Stanford University, California Institute for Regenerative Medicine (CIRM).
Usc/chla Cell Therapy Program Questions
Usc/Chla Cell Therapy Program's website is https://keck.usc.edu/cell-therapy-program/
Usc/Chla Cell Therapy Program's LinkedIn profile is https://www.linkedin.com/company/usc-chla-cell-therapy-program
Usc/Chla Cell Therapy Program has
13 employees.
View email and phone details for 13
employees at Usc/Chla Cell Therapy Program.
Usc/Chla Cell Therapy Program's industry is
Pharmaceutical Manufacturing
Usc/Chla Cell Therapy Program's top competitors are
Allogene Therapeutics,
Northwestern Medicine Department Of Ophthalmology,
Keck Medicine Of Usc,
American Chinese Pharmaceutical Association,
Cedars-Sinai Biomanufacturing Center,
Innovative Strategies & Solutions Inc.,
Children's Hospital Los Angeles (Chla),
Cedars-Sinai Technology Ventures,
Women's Community Center @ Stanford University,
California Institute For Regenerative Medicine (Cirm).
Usc/Chla Cell Therapy Program's categories are Pharmaceutical Manufacturing
Usc/Chla Cell Therapy Program's founding year is 2021
